THE MITOGEN-ACTIVATED PROTEIN KINASE p38 IS NECESSARY FOR INTERLEUKIN-1β-INDUCED MONOCYTE CHEMOATTRACTANT PROTEIN 1 EXPRESSION BY HUMAN MESANGIAL CELLS

b h rovin,william a wilmer,michele m danne,julie a dickerson,cynthia dixon,linrong lu
DOI: https://doi.org/10.1006/cyto.1998.0409
IF: 3.926
1999-01-01
Cytokine
Abstract:Mitogen-activated protein (MAP) kinases have been suggested as potential mediators for interleukin 1 beta (IL-1 beta)-induced gene activation. This study investigated the role of the MAP kinases p38 and ERK2 in IL-1 beta-mediated expression of the chemokine MCP-1 by human mesangial cells. Phosphorylation of p38 kinase, which is necessary for activation, increased significantly after IL-1 beta treatment. p38 kinase immunoprecipitated from IL-1 beta-treated cells phosphorylated target substrates to a greater extent than p38 kinase from controls. SE 203580, a selective p38 kinase inhibitor, was used to examine the role of p38 kinase in MCP-1 expression. SE 203580 decreased IL-1 beta-induced MCP-1 mRNA and protein levels, but did not affect MCP-1 mRNA stability. Because NF-kappa B is necessary for MCP-1 gene expression, the effect of p38 kinase inhibition on IL-1 beta induction of NF-kappa B was measured. SE 203580 (up to 25 mu M) had no effect on IL-1 beta-induced NF-kappa B nuclear translocation or DNA binding activity. Our previous work showed that IL-1 beta also activates the MAP kinase ERK2 in human mesangial cells. PD 098059, a selective inhibitor of the ERK activating kinase MEK1, had no effect on IL-1 beta-induced MCP-1 mRNA or protein levels, or on IL-1 beta activation of NF-kappa B. These data indicate that p38 kinase is necessary for the induction of MCP-1 expression by IL-1 beta, but is not involved at the level of cytoplasmic activation of NF-kappa B. In contrast, ERK2 does not mediate IL-1 beta-induced MCP-1 gene expression. (C) 1999 Academic Press.
What problem does this paper attempt to address?